Knode has sprung to life with web-based software to enable life sciences stakeholders to hunt for top experts.

Sold on the growing need for data in biopharma, India's Piramal Healthcare has scooped up Decision Resources Group in deal valued at about $635 million.

As we pack more data about our health into mobile devices, pharma companies could face a new competitive threat to their drugs: Mobile health apps.

As GenomeWeb reports, the National Institutes of Health's National Institute on Aging has heeded the president's call for action and awarded up to $6 million for three projects that aim to analyze DNA sequencing data related to Alzheimer's.

BioClinica ($BIOC) capitalized on the compatibility of its clinical trials software with Microsoft ($MSFT) technology and boosted revenue and income during the first quarter that ended March 31, the company said last week.

Boehringer Ingelheim wants to create a social game dubbed "Syrum" that would let players tend to virtual R&D projects and traffic in scientific talent and compounds, according to InPharm.

Roche's 454 Life Sciences has struck a partnership with SoftGenetics, a provider of next-generation sequencing (NGS) analytics. The co-op calls for Roche/454 and SoftGenetics to join forces in production promotions, the software company says.

In an effort to engineer a turnaround at the struggling giant, AstraZeneca ($AZN) has zeroed in on information technology projects that could deliver results. And Angela Yochem, the company's technology chief since last year, has been digging into the miscues at the global company.